[adinserter block="2"]
No Picture
News

Manufacturing roundup: AGC Biologics to manufacture diabetes therapy; Cambrex caps acquisition of Snapdragon Chemistry

The Washington-based CDMO AGC Biologics has been tapped to manufacture the type 1 diabetes treatment Tzield from Provention Bio. AGC Biologics will produce Tzield at its Seattle protein biologics site. It was chosen after AGC […]

[adinserter block="2"]
[adinserter block="2"]
No Picture
News

Cerebral Therapeutics Names Julie Foster as Chief Operating Officer

AURORA, Colo.–(BUSINESS WIRE)–Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment of MedTech industry veteran Julie Foster as Chief Operating Officer. Julie succeeds John Foster who served as […]